Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 11Genitourinary 2Gastrointestinal 2Breast 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1

Conditions

Neoplasm Recurrence, Local 1Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gadolinium × Gastrointestinal × Clear all
NCT02057874 2018-07-11

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
2 enrolled 4 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT01895673 2016-12-15

PET-MRI After Radiofrequency Ablation (RFA) or Microwave Ablation (MWA)

Amsterdam UMC, location VUmc

Completed
20 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡